Pull‐down assays by NCAPH probes further affirmed the interaction between NCAPH mRNA and METTL3, YTHDC1 and IGF2BP3 in both ccRCC cell lines (Figure 3I). The gene discussed is METTL3; the disease is nonpapillary renal cell carcinoma.